James Brook | Head of EMEA, Tigermed
James Brook joined Tigermed Group on the 1st June 2021. He has over 25 years experience in the industry with senior positions at IQVIA (formerly Quintiles), GSK, Novartis and Wyeth, with proven track record of leadership across multiple functional areas including Project Management, Therapeutic Strategy, Change Management, and Clinical. Prior to Tigermed, he was the Head of UK and Ireland Clinical for IQVIA delivering over 340 trials and 20% of the commercial UK research market.
About Tigermed
Tigermed (Stock code: 300347.SZ/3347.HK) is a leading provider of innovative clinical research solutions across full lifecycle of biopharmaceutical and medical device products globally. With a broad portfolio of services and a promise of quality, from clinical development to commercialization, we are committed to moving our customers and patients through their development journey efficiently and cost-effectively, embracing challenges to fulfill our commitment to serve unmet patients’ needs.
Sponsors & Partners
| Powered by: Hyphen Projects | Connect with us | Access Biotech China Newsletter | ||
| Contact Us Privacy Policy Terms & Conditions Chamber of Commerce: 32110979 VAT no: NL8184.34.491.B01 |
| Subscribe
|
© Copyright 2021 by Hyphen Projects